Gabelli Funds’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-741,000
Closed -$59.4M 1206
2016
Q4
$59.4M Buy
741,000
+220,826
+42% +$17.5M 0.35% 70
2016
Q3
$41.5M Sell
520,174
-76,226
-13% -$6.15M 0.25% 120
2016
Q2
$46.5M Buy
596,400
+471,400
+377% +$33.6M 0.27% 100
2016
Q1
$6.88M Sell
125,000
-5,000
-4% -$272K 0.04% 456
2015
Q4
$8.03M Buy
130,000
+30,000
+30% +$1.89M 0.05% 434
2015
Q3
$6.31M Hold
100,000
0.04% 497
2015
Q2
$7.31M Sell
100,000
-35,000
-26% -$2.53M 0.04% 490
2015
Q1
$8.83M Sell
135,000
-31,000
-19% -$2.06M 0.04% 462
2014
Q4
$10.8M Sell
166,000
-10,000
-6% -$644K 0.05% 423
2014
Q3
$10.6M Sell
176,000
-5,000
-3% -$327K 0.05% 424
2014
Q2
$12.5M Hold
181,000
0.06% 388
2014
Q1
$11.8M Buy
181,000
+2,500
+1% +$163K 0.06% 388
2013
Q4
$11.1M Sell
178,500
-5,000
-3% -$290K 0.06% 399
2013
Q3
$9.84M Buy
183,500
+42,500
+30% +$2.19M 0.06% 407
2013
Q2
$6.43M Buy
+141,000
New +$6.11M 0.04% 469

Other funds holding STJ

Gabelli Funds's STJ Position: Q1 2017 in Review

Gabelli Funds sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 741,000 shares — an estimated $59.4M sold.

Gabelli Funds first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $59.4M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Gabelli Funds reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Gabelli Funds sold 741,000 St Jude Medical shares in Q1 2017, an estimated $59.4M.
  • Gabelli Funds first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Gabelli Funds's St Jude Medical position peaked at $59.4M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Gabelli Funds's 13F filing for Q1 2017, filed 4 May 2017.